AllianceBernstein’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05M | Buy |
47,040
+2,050
| +5% | +$89.5K | ﹤0.01% | 1919 |
|
|
2025
Q1 | $1.23M | Sell |
44,990
-43,256
| -49% | -$1.18M | ﹤0.01% | 2135 |
|
|
2024
Q4 | $3.55M | Sell |
88,246
-36,368
| -29% | -$1.46M | ﹤0.01% | 1658 |
|
|
2024
Q3 | $5.9M | Buy |
124,614
+30,946
| +33% | +$1.46M | ﹤0.01% | 1451 |
|
|
2024
Q2 | $2.8M | Sell |
93,668
-8,435
| -8% | -$252K | ﹤0.01% | 1767 |
|
|
2024
Q1 | $4.1M | Buy |
102,103
+63,703
| +166% | +$2.56M | ﹤0.01% | 1549 |
|
|
2023
Q4 | $978K | Buy |
38,400
+400
| +1% | +$10.2K | ﹤0.01% | 2282 |
|
|
2023
Q3 | $528K | Hold |
38,000
| – | – | ﹤0.01% | 2540 |
|
|
2023
Q2 | $874K | Hold |
38,000
| – | – | ﹤0.01% | 2347 |
|
|
2023
Q1 | $1.13M | Hold |
38,000
| – | – | ﹤0.01% | 2169 |
|
|
2022
Q4 | $948K | Hold |
38,000
| – | – | ﹤0.01% | 2312 |
|
|
2022
Q3 | $827K | Hold |
38,000
| – | – | ﹤0.01% | 2394 |
|
|
2022
Q2 | $748K | Sell |
38,000
-23,614
| -38% | -$465K | ﹤0.01% | 2494 |
|
|
2022
Q1 | $2.61M | Buy |
61,614
+24,914
| +68% | +$1.05M | ﹤0.01% | 1927 |
|
|
2021
Q4 | $2.33M | Hold |
36,700
| – | – | ﹤0.01% | 2035 |
|
|
2021
Q3 | $2.16M | Sell |
36,700
-900
| -2% | -$52.9K | ﹤0.01% | 2116 |
|
|
2021
Q2 | $1.82M | Buy |
37,600
+26,800
| +248% | +$1.3M | ﹤0.01% | 2239 |
|
|
2021
Q1 | $420K | Buy |
10,800
+4,000
| +59% | +$156K | ﹤0.01% | 2731 |
|
|
2020
Q4 | $422K | Buy |
+6,800
| New | +$422K | ﹤0.01% | 2654 |
|